G Protein-Coupled Receptor Kinase 2 Ablation in Cardiac Myocytes Before or After Myocardial Infarction Prevents Heart Failure

Myocardial G protein-coupled receptor kinase (GRK)2 is a critical regulator of cardiac &bgr;-adrenergic receptor (&bgr;AR) signaling and cardiac function. Its upregulation in heart failure may further depress cardiac function and contribute to mortality in this syndrome. Preventing GRK2 translocation to activated &bgr;AR with a GRK2-derived peptide that binds G&bgr;&ggr; (&bgr;ARKct) has benefited some models of heart failure, but the precise mechanism is uncertain, because GRK2 is still present and &bgr;ARKct has other potential effects. We generated mice in which cardiac myocyte GRK2 expression was normal during embryonic development but was ablated after birth (&agr;MHC-Cre×GRK2 fl/fl) or only after administration of tamoxifen (&agr;MHC-MerCreMer×GRK2 fl/fl) and examined the consequences of GRK2 ablation before and after surgical coronary artery ligation on cardiac adaptation after myocardial infarction. Absence of GRK2 before coronary artery ligation prevented maladaptive postinfarction remodeling and preserved &bgr;AR responsiveness. Strikingly, GRK2 ablation initiated 10 days after infarction increased survival, enhanced cardiac contractile performance, and halted ventricular remodeling. These results demonstrate a specific causal role for GRK2 in postinfarction cardiac remodeling and heart failure and support therapeutic approaches of targeting GRK2 or restoring &bgr;AR signaling by other means to improve outcomes in heart failure.

[1]  R. Lefkowitz,et al.  Intracoronary adenovirus-mediated delivery and overexpression of the beta(2)-adrenergic receptor in the heart : prospects for molecular ventricular assistance. , 2000, Circulation.

[2]  B. Kobilka,et al.  Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Boerries,et al.  Cardiac adenoviral S100A1 gene delivery rescues failing myocardium. , 2004, The Journal of clinical investigation.

[4]  G. Dorn,et al.  β1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure , 2003, Nature Medicine.

[5]  P. Clopton,et al.  Increased Cardiac Adenylyl Cyclase Expression Is Associated With Increased Survival After Myocardial Infarction , 2006, Circulation.

[6]  R. Lefkowitz,et al.  Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. , 1994, Science.

[7]  S. Vatner,et al.  Adverse Effects of Chronic Endogenous Sympathetic Drive Induced by Cardiac Gsα Overexpression , 1996 .

[8]  N. Dalton,et al.  Intracoronary Adenovirus Encoding Adenylyl Cyclase VI Increases Left Ventricular Function in Heart Failure , 2004, Circulation.

[9]  R. Lefkowitz,et al.  Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Lohse,et al.  Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Dunlap.  New Studies Influencing Treatment of Heart Failure: 2006 Update , 2007, Pharmacotherapy.

[12]  W. Pu,et al.  Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase. , 2006, Journal of cardiac failure.

[13]  M. Crackower,et al.  Temporally Regulated and Tissue-Specific Gene Manipulations in the Adult and Embryonic Heart Using a Tamoxifen-Inducible Cre Protein , 2001, Circulation research.

[14]  D. Leosco,et al.  Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. , 2005, European heart journal.

[15]  J. Ross,et al.  Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[16]  B. A. French,et al.  Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. , 1997, The Journal of clinical investigation.

[17]  S. Goldstein.  Benefits of beta-blocker therapy for heart failure: weighing the evidence. , 2002, Archives of internal medicine.

[18]  W. Koch,et al.  Targeted &bgr;-Adrenergic Receptor Kinase (&bgr;ARK1) Inhibition by Gene Transfer in Failing Human Hearts , 2004 .

[19]  R. Lefkowitz,et al.  Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Emani,et al.  In Vivo Ventricular Gene Delivery of a &bgr;-Adrenergic Receptor Kinase Inhibitor to the Failing Heart Reverses Cardiac Dysfunction , 2001, Circulation.

[21]  R. Lefkowitz,et al.  Level of beta-adrenergic receptor kinase 1 inhibition determines degree of cardiac dysfunction after chronic pressure overload-induced heart failure. , 2005, Circulation.

[22]  G. Dorn,et al.  Low- and high-level transgenic expression of beta2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galphaq-overexpressing mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Violin,et al.  Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection. , 2007, The Journal of clinical investigation.

[24]  G. Dorn,et al.  Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level. , 2000, Circulation.

[25]  J. Violin,et al.  β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection , 2007 .

[26]  Magdi H Yacoub,et al.  Left ventricular assist device and drug therapy for the reversal of heart failure. , 2006, The New England journal of medicine.

[27]  M. Lohse,et al.  Effects of two Gbetagamma-binding proteins--N-terminally truncated phosducin and beta-adrenergic receptor kinase C terminus (betaARKct)--in heart failure. , 2003, Gene therapy.

[28]  M. Böhm,et al.  Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. , 1993, Circulation.

[29]  S. Vatner,et al.  Adverse effects of chronic endogenous sympathetic drive induced by cardiac GS alpha overexpression. , 1996, Circulation research.

[30]  T. Anzai,et al.  Adenylylcyclase increases responsiveness to catecholamine stimulation in transgenic mice. , 1999, Circulation.

[31]  R. Lefkowitz,et al.  Overexpression of the cardiac beta(2)-adrenergic receptor and expression of a beta-adrenergic receptor kinase-1 (betaARK1) inhibitor both increase myocardial contractility but have differential effects on susceptibility to ischemic injury. , 1999, Circulation research.

[32]  E. Lakatta,et al.  Erratum: Culture and adenoviral infection of adult mouse cardiac myocytes: Methods for cellular genetic physiology (American Journal of Physiology - Heart and Circulatory Physiology (July 2000) 279:48 (H429-H436)) , 2000 .

[33]  M. Lohse,et al.  Effects of two Gβγ-binding proteins – N-terminally truncated phosducin and β-adrenergic receptor kinase C terminus (βARKct) – in heart failure , 2003, Gene Therapy.

[34]  Robert J. Lefkowitz,et al.  Seven-transmembrane-spanning receptors and heart function , 2002, Nature.

[35]  W. Koch,et al.  Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts. , 2004, Circulation.

[36]  G. Dorn,et al.  Cardiac-Specific Ablation of G-Protein Receptor Kinase 2 Redefines Its Roles in Heart Development and &bgr;-Adrenergic Signaling , 2006, Circulation research.

[37]  A. Takeshita,et al.  Disruption of Inducible Nitric Oxide Synthase Improves &bgr;-Adrenergic Inotropic Responsiveness but Not the Survival of Mice With Cytokine-Induced Cardiomyopathy , 2002, Circulation research.

[38]  S. Vatner,et al.  Effects of chronic beta-adrenergic receptor stimulation in mice. , 1997, Journal of molecular and cellular cardiology.

[39]  G. Dorn,et al.  Low- and high-level transgenic expression of β2-adrenergic receptors differentially affect cardiac hypertrophy and function in Gαq-overexpressing mice , 1999 .

[40]  R. Lefkowitz,et al.  New roles for beta-arrestins in cell signaling: not just for seven-transmembrane receptors. , 2006, Molecular cell.

[41]  S. Goldstein.  Benefits of β-Blocker Therapy for Heart Failure: Weighing the Evidence , 2002 .

[42]  R. Lefkowitz,et al.  Level of &bgr;-Adrenergic Receptor Kinase 1 Inhibition Determines Degree of Cardiac Dysfunction After Chronic Pressure Overload–Induced Heart Failure , 2005 .

[43]  M. Völkers,et al.  Cardiac S100A1 Protein Levels Determine Contractile Performance and Propensity Toward Heart Failure After Myocardial Infarction , 2006, Circulation.

[44]  M. Bristow.  Why does the myocardium fail? Insights from basic science , 1998, The Lancet.

[45]  M. Caron,et al.  Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[46]  E. Olson,et al.  Dilated Cardiomyopathy and Sudden Death Resulting From Constitutive Activation of Protein Kinase A , 2001, Circulation research.

[47]  E. Lakatta,et al.  Culture and adenoviral infection of adult mouse cardiac myocytes: methods for cellular genetic physiology. , 2000, American journal of physiology. Heart and circulatory physiology.

[48]  Donald M Bers,et al.  Cellular Basis of Abnormal Calcium Transients of Failing Human Ventricular Myocytes , 2003, Circulation research.

[49]  W. Koch,et al.  The adrenergic pathway and heart failure. , 2004, Recent progress in hormone research.

[50]  W. Koch,et al.  Myocardial function in hearts with transgenic overexpression of the G protein-coupled receptor kinase 5. , 2001, The Annals of thoracic surgery.

[51]  G. Andersen,et al.  Myocardial distribution and regulation of GRK and beta-arrestin isoforms in congestive heart failure in rats. , 2001, American journal of physiology. Heart and circulatory physiology.